Financial News
Latest News about BMY
Recent news which mentions BMY
3 Warren Buffett Stocks to Buy Hand Over Fist in February
February 07, 2022
From Motley Fool
Bristol-Myers Squibb (BMY) Q4 2021 Earnings Call Transcript
February 04, 2022
Tickers
BMY
From Motley Fool
5 Biotech Stocks to Buy to Benefit From Biden’s New Cancer Cabinet
February 04, 2022
From InvestorPlace
Bristol Myers Q4 Revenue, FY22 Sales Outlook Lag Consensus
February 04, 2022
Tickers
BMY
From Benzinga
The Daily Biotech Pulse: Sanofi, Bristol-Myers Squibb Gain On Earnings, Valneva-Pfizer Tout Positive Lyme Disease Vaccine Data, UNITY Biotech Restructures
February 04, 2022
From Benzinga
5 Stocks To Watch For February 4, 2022
February 04, 2022
From Benzinga
Earnings Scheduled For February 4, 2022
February 04, 2022
From Benzinga
Psoriasis Drug Providers Looking Over Shoulders At Upcoming Competitor?
February 03, 2022
From Benzinga
The Daily Biotech Pulse: Big Pharma Earnings Prove Lackluster, Mersana Inks $1B ADC R&D Deal, Syros Gets Orphan Drug Designation
February 03, 2022
From Benzinga
Amendments To Canada's Special Access Program (SAP) Allows Access To Restricted Psychedelic Drugs. How Will This Affect The Industry?
February 02, 2022
From Benzinga
3 Pharmaceutical Stocks With Dividend Yields of 2.9% or Better
February 01, 2022
From Motley Fool
5 Things To Expect This Week
January 31, 2022
From InvestorPlace
10 Health Care Stocks Whale Activity In Today's Session
January 31, 2022
From Benzinga
Are Warren Buffett's 3 Cheapest Stocks Screaming Buys?
January 31, 2022
From Motley Fool
How to Invest in Biotech When Deep Value Has no Discernible Meaning
January 31, 2022
From Motley Fool
The Week Ahead In Biotech (Jan 31-Feb 5): Merck, Bristol-Myers Squibb, Lilly & Novartis Headline Large-Cap Biopharma Earnings News
January 31, 2022
From Benzinga
EMA's Advisory Committee Recommends Approval Of Bristol-Myers' Breyanzi In Lymphoma
January 28, 2022
Tickers
BMY
From Benzinga
Say Hello to 2022’s Dogs of the Dow: 10 Dividend Stocks to Watch
January 27, 2022
From InvestorPlace
2 Dirt-Cheap Dividend Stocks to Buy and Hold Forever
January 27, 2022
From Motley Fool
Hoth's Management Team And Scientific Advisory Board Report Wrapping Up A Busy 2021 Of Clinical Research
January 27, 2022
From Benzinga
The Daily Biotech Pulse: Gilead's Blood Cancer Studies Placed On Partial Clinical Hold, Immunocore Gets FDA Nod, NRx Touts Positive COVID-19 Data
January 26, 2022
From Benzinga
5 Buffett Stocks to Buy Hand Over Fist in 2022
January 24, 2022
From Motley Fool
What's the Outlook for Illumina?
January 23, 2022
From Motley Fool
What's Behind Bristol Myers Squibb's Latest Partnership?
January 22, 2022
From Motley Fool
4 Perfect Dividend Stocks to Buy if There's a Stock Market Crash
January 20, 2022
From Motley Fool
3 Healthcare Stocks Ignoring the Market Mayhem
January 19, 2022
From InvestorPlace
2 Best Warren Buffett Dividend Stocks to Buy Now
January 19, 2022
From Motley Fool
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.